Autopsy report · NCT05700903
Contributions to Hypertension With Androgen Deprivation Therapy
Cause of deathOther
“Study completed”
Life of this trial
- Registered 8 months before it started.
- Ran for about 1 year 10 months before it stopped.
- 10 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- University of Colorado, Denver
- Sponsor type
- University, hospital or other
- Conditions
- Androgen Deprivation Therapy; Prostate Cancer; Hypertension; Autonomic Dysfunction; Renal Disease
- Interventions
- Gonadotropin Releasing Hormone Agonists (GNRH); Androgen receptor (AR) inhibitor; Placebo
- Participants
- 10
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.